Wireless blood glucose testing arrives

The first wireless POC (Point of care) blood glucose and bedside testing solution for hospitals was launched by Bayer Healthcare during the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Amsterdam this September.

Photo: Wireless blood glucose testing arrives

Called Contour pro, the new system uses a secure Bluetooth connection to transmit, from the point of care to a PDA, the test data and patient’s key data for further processing within the hospital’s IT system. ‘This solution enables the hospital staff to access all patient and quality control results and provides an accessible real-time patient record at bedside,’ Bayer reports. ‘Contour Pro possesses the well established “no coding” technology that delivers accurate results and therefore improves therapeutic success. Coding errors are a major problem because they can lead to inaccuracies in blood glucose measurements and, in the long term, inaccurate readings can hide poor glycaemic control, which can lead to serious complications.’
 The device manages not only glucose, but all POC bedside testing data, and has no maltose or galactose interferences, Bayer points out. ‘An automatic interference correction electrode provides superior stability with common reducing substances.’
In Europe, the Contour Pro blood glucose monitoring system will be launched in selected areas early in 2008.
Full details: www.viva.vita.bayerhealthcare.com


Related articles


Sponsored • Digital solutions for radiology

How to accelerate healthcare innovation in AI

Tapping the thriving Radiology AI ecosystem, Bayer recently announced three collaboration agreements for its digital platform, Calantic Digital Solutions, as well as an AI accelerator program.


Article •

Bayer in cancer collaboration

Finnish pharma company Orion and German healthcare giant Bayer have entered into an agreement for the development and commercialisation of a novel drug targeting prostate cancer.


Article •

Move to significantly strengthen position in consumer care

Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA, for a purchase price of USD 14.2 billion (EUR 10.4 billion).

Related products

Subscribe to Newsletter